Intrinsic Imaging Joins Metastatic Colorectal Cancer Trial

May 24, 2011 — Biopharmaceutical medical imaging services firm Intrinsic Imaging will be participating in a five-year multicenter clinical trial related to the treatment of metastatic colorectal cancer.

The San Antonio-based firm said it would provide imaging core lab services to manage acquisition, transfer, and processing of images from hundreds of patients from more than 40 investigator sites. Intrinsic will also provide its team of oncology-subspecialized radiologists for image interpretation during the trial.